Affiliation:
1. Clinical Research on Skin Diseases School of Clinical Medicine, Chengdu University of TCM, Chengdu 610072, China
2. Department of Medical Cosmetology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu 610072, China
3. Dermatology of Department, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu 610072, China
Abstract
Background. Chloasma is a common skin pigment disorder. Treatment of chloasma has been challenging, often unsatisfactory, and difficult to avoid recurrence. PRP is a new treatment for chloasma, but there is no consensus on its use. Lingyun Zhao’s team recently reported a systematic evaluation and meta-analysis of the efficacy and safety of PRP in the treatment of chloasma, which is consistent with our ideas, but we will elaborate on the application of PRP in chloasma from a deeper and more comprehensive perspective. Before we started this study, we had registered with Prospero as CRD42021233721. Methods. The authors searched the public medical network, MEDLINE, EMBASE, Cochrane Central Register of Controlled Trials, ScienceDirect, Scopus, and Science Network. The clinical trials registry ClinicalTrials.gov databases were searched for relevant publications to June 2021. The results showed the area and severity of chloasma (MASI) or revised MASI (mMASI) score. Results. Three RCTs, one nonrandomized controlled study, and four were prospective before and after self-controlled studies met the inclusive criteria. Intradermal PRP injections significantly improved chloasma as indicated by the significant decrease MASI (average balance -6.71, 95% CI -8.99 to -4.33) and mMASI scores (average balance -2.94, 95% CI -4.81 to -1.07). The adverse reactions were mild, and there were no significant long-term adverse events. Conclusive. The data can reflect the effectiveness and safety of PRP therapy for chloasma. RCTs are needed to determine effective treatment parameters, and long-term follow-up should be included to better clarify the efficacy and side effects of PRP in treating chloasma.
Funder
Chengdu University of Traditional Chinese Medicine
Subject
General Mathematics,General Medicine,General Neuroscience,General Computer Science
Reference27 articles.
1. Comparing the efficacy of patelet-rich plasma (PRP) versus tranexamic acid (4mg/mL) as intradermal treatments of chloasma;M. Maryam;Journal of the College of Physicians and Surgeons--Pakistan,2021
2. Autologous intralesional platelet rich plasma improves melasma
3. Platelet-rich plasma is a useful therapeutic option in melasma
4. Platelet‐rich plasma treatment for melasma: A pilot study
5. Regression of Chloasma with platelet-rich plasma treatment;M. Cayırlı;Annals of Dermatology,2014
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献